홈 > 시장보고서 > 의약품

시장보고서

상품코드

1705700

세계의 만성 질환 관리 시장 : 질환 유형별, 서비스 유형별, 배포 모드별, 최종 사용자별, 지역별

Chronic Disease Management Market, By Disease Type, By Service Type, By Delivery Mode, By End User, By Geography

발행일: 2025년 02월 | 리서치사:

Coherent Market Insights | 페이지 정보: 영문 | 배송안내 : 2-3일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 만성 질환 관리 시장은 2025년 64억 9,000만 달러로 추정되고, 2032년까지 158억 5,000만 달러에 이를 것으로 예측되며, 2025년부터 2032년까지 CAGR 13.6%로 성장할 전망입니다.

보고 범위		보고서 세부정보
기준연도	2024년	2025년 시장 규모	64억 9,000만 달러
실적 데이터	2020-2024년	예측 기간	2025-2032년
예측 기간: 2025-2032년 CAGR:	13.60%	2032년 가치 예측	158억 5,000만 달러

그림. 만성 질환 관리 시장의 지역별 점유율(%)(2025년)

당뇨병, 암, 심혈관 질환(CVD), 만성 폐색성 폐 질환(COPD), 천식 등의 만성 질환은 지속적인 의료를 필요로 하고 일상생활을 제한하는 장기적인 건강상태입니다. 스트레스가 많은 생활이 이러한 증상을 관리하기 어려워지고 있으며, 이로 인해 보다 우수한 만성 질환 관리 기술에 대한 수요가 높아지고 있습니다.

시장 역학:

세계의 만성 질환 관리 시장의 성장은 복수의 만성 질환을 가진 노인 인구 증가, 비만과 식생활의 변화에 의한 당뇨병이나 심혈관 질환 등의 생활 습관병의 이환율 증가, 질병의 조기 발견과 질환 관리의 이점에 대한 의식 증가, 디지털 헬스 솔루션의 기술 진보, 의료비 증가를 억제하기 위한 다양한 정부나 민간 조직의 노력 등의 요인에 의해 초래됩니다. 그러나, 데이터 프라이버시에 대한 우려, 원격 모니터링 장비 및 서비스 도입 비용의 높이, 개발도상국에서의 숙련된 헬스케어 전문가의 부족 등이, 보다 신속한 보급의 방해가 될 가능성이 있습니다.복수의 병태를 관리하는 통합 플랫폼의 개발, AI와 웨어러블 기술의 역할 확대, 개별화 케어에 대한 주목 상승이 시장 기업에게 유리한 성장 기회를 제공합니다.

본 조사의 주요 특징

본 보고서에서는 세계의 만성질환 관리 시장을 상세하게 분석하여 2024년을 기준연도로 한 예측기간(2025-2032년) 시장 규모(10억 달러)와 연간 평균 성장률(CAGR%)을 제공합니다.

또한 다양한 부문에 걸친 잠재적인 수익 기회를 밝히고 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.

또한 시장 성장 촉진요인, 억제요인, 기회, 신제품의 상시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 중요한 고찰도 제공합니다.

세계의 만성 질환 관리 시장에서 주요 기업을 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등의 매개변수를 기반으로 프로파일링하고 있습니다.

본 조사의 대상이 되는 주요 기업에는 IBM, Cerner Corporation, Epic Systems, McKesson Corporation, Athenahealth, Healthagen, Allscripts, Optum(A Part of UnitedHealth Group), Conifer Health Solutions, NXGN Management, Phytel, I2I Population Health, Healthwise가 포함됩니다.

이 보고서의 인사이트를 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 타이핑, 시장 확대, 마케팅 전술에 대한 정보를 바탕으로 의사 결정을 내릴 수 있습니다.

세계의 만성질환 관리 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등 이 업계의 다양한 이해관계자를 지원합니다.

이해관계자들은 세계의 만성질환 관리 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사 결정이 용이해집니다.

기업 프로파일
- UnitedHealth Group
- CVS Health
- Cigna
- Anthem, Inc.
- Aetna(a CVS Health company)
- Mayo Clinic
- Kaiser Permanente
- Humana Inc.
- Teladoc Health, Inc.
- McKesson Corporation
- Cerner Corporation
- Epic Systems Corporation
- Medtronic
- Abbott Laboratories
- Novartis AG
- Roche Holding AG
- Bristol-Myers Squibb
- Johns Hopkins Medicine
- GE Healthcare
- Philips Healthcare

제11장 분석가 추천

운명의 원
애널리스트의 견해
일관성 있는 기회 맵

제12장 참고문헌과 조사방법

참고문헌
조사 방법

JHS 25.05.19

Global Chronic Disease Management Market is estimated to be valued at USD 6.49 Bn in 2025 and is expected to reach USD 15.85 Bn by 2032, growing at a compound annual growth rate (CAGR) of 13.6% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 6.49 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	13.60%	2032 Value Projection:	USD 15.85 Bn

Figure. Chronic Disease Management Market Share (%), By Region 2025

Chronic diseases, such as diabetes, cancer, cardiovascular diseases (CVD), chronic obstructive pulmonary disease (COPD), and asthma are long-term health conditions that require ongoing medical care and limit daily activities. These are largely preventable through lifestyle changes, like avoiding tobacco and maintaining healthy weight. However, busy schedules and stressful lives have made managing such conditions challenging. This has boosted demand for better chronic disease management techniques. Various technological advancements in remote patient monitoring and growing efforts by governments to improve healthcare infrastructure can drive the market growth in the near future.

Market Dynamics:

Global chronic disease management market growth is driven by factors like growing geriatric population burdened by multiple chronic conditions, increasing incidence of lifestyle diseases such as diabetes and cardiovascular diseases due to obesity and changing dietary patterns, growing awareness about benefits of early disease detection and disease management, technological advances in digital health solutions, and initiatives by various governments and private organizations to curb rising healthcare costs. However, data privacy concerns, high deployment costs of remote monitoring devices and services, and lack of skilled healthcare professionals in developing nations can hamper faster adoption. Development of integrated platforms to manage multiple conditions, expanding role of AI and wearable technologies, and growing focus on personalized care provide lucrative growth opportunities for market players.

Key features of the study:

This report provides in-depth analysis of the global chronic disease management market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global chronic disease management market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include IBM, Cerner Corporation, Epic Systems, McKesson Corporation, Athenahealth, Healthagen, Allscripts, Optum (A Part of UnitedHealth Group), Conifer Health Solutions, NXGN Management, Phytel, I2I Population Health, and Healthwise

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global chronic disease management market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global chronic disease management market

Detailed Segmentation-

Disease Type Insights (Revenue, USD Bn, 2020 - 2032)
- Cardiovascular Diseases
- Diabetes
- Respiratory Diseases
- Cancer
- Chronic Kidney Disease
- Others (Arthritis, etc.)
Service Type Insights (Revenue, USD Bn, 2020 - 2032)
- Disease Management Programs
- Remote Patient Monitoring
- Telehealth Services
- Others (Diagnostic Services, etc.)
Delivery Mode Insights (Revenue, USD Bn, 2020 - 2032)
- On-premise
- Web-based
- Cloud-based
End User Insights (Revenue, USD Bn, 2020 - 2032)
- Hospitals
- Specialty Clinics
- Home Care Settings
- Others (Pharmaceutical Companies, etc.)
Regional Insights (Revenue, USD Bn 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- UnitedHealth Group
- CVS Health
- Cigna
- Anthem, Inc.
- Aetna (a CVS Health company)
- Mayo Clinic
- Kaiser Permanente
- Humana Inc.
- Teladoc Health, Inc.
- McKesson Corporation
- Cerner Corporation
- Epic Systems Corporation
- Medtronic
- Abbott Laboratories
- Novartis AG
- Roche Holding AG
- Bristol-Myers Squibb
- Johns Hopkins Medicine
- GE Healthcare
- Philips Healthcare

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Disease Type
- Market Snapshot, By Service Type
- Market Snapshot, By Delivery Mode
- Market Snapshot, By End User
- Market Snapshot, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Chronic Disease Management Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Chronic Disease Management Market, By Disease Type, 2021 - 2032, (USD Bn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Cardiovascular Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Diabetes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Respiratory Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Cancer
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Chronic Kidney Disease
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Chronic Disease Management Market, By Service Type, 2021 - 2032, (USD Bn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Disease Management Programs
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Remote Patient Monitoring
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Telehealth Services
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Chronic Disease Management Market, By Delivery Mode, 2021 - 2032, (USD Bn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
On-premise
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Web-based
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Cloud-based
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Chronic Disease Management Market, By End User, 2021 - 2032, (USD Bn)

Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Specialty Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Home Care Settings
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Chronic Disease Management Market, By Region, 2021 - 2032, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021-2032
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery Mode, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2032, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery Mode, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2032, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery Mode, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2032, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery Mode, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2032, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery Mode, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2032, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Service Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Delivery Mode, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2032, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

10. Competitive Landscape

Company Profiles
- UnitedHealth Group
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- CVS Health
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Cigna
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Anthem, Inc.
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Aetna (a CVS Health company)
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Mayo Clinic
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Kaiser Permanente
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Humana Inc.
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Teladoc Health, Inc.
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- McKesson Corporation
- Cerner Corporation
- Epic Systems Corporation
- Medtronic
- Abbott Laboratories
- Novartis AG
- Roche Holding AG
- Bristol-Myers Squibb
- Johns Hopkins Medicine
- GE Healthcare
- Philips Healthcare

11. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

12. References and Research Methodology

References
Research Methodology
About us and Sales Contact

02-2025-2992
(주말 및 공휴일 제외)

라이선스 / 가격

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 4,500

￦ 6,333,000

PDF (Multi User License)

PDF 보고서를 동일 사업장에서 7명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 7,000

￦ 9,852,000

PDF (Enterprise User License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000

￦ 14,075,000

※ 부가세 별도

세계의 만성 질환 관리 시장 : 질환 유형별, 서비스 유형별, 배포 모드별, 최종 사용자별, 지역별

Chronic Disease Management Market, By Disease Type, By Service Type, By Delivery Mode, By End User, By Geography

시장 역학:

본 조사의 주요 특징

목차

제1장 조사의 목적과 전제조건

제2장 시장 전망

제3장 시장 역학, 규제, 동향 분석

제4장 세계의 만성 질환 관리 시장 - 코로나바이러스(COVID-19) 유행의 영향

제5장 세계의 만성 질환 관리 시장, 질환 유형별, 2021-2032년

제6장 세계의 만성 질환 관리 시장, 서비스 유형별, 2021-2032년

제7장 세계의 만성 질환 관리 시장, 전달 모드별, 2021-2032년

제8장 세계의 만성질환 관리 시장, 최종 사용자별, 2021-2032년

제9장 세계의 만성질환 관리 시장, 지역별, 2021-2032년

제10장 경쟁 구도